Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46820 | 14698985 | Endocr Pract | Insulin resistance syndrome and nonalcoholic fatty liver disease. | 2004 | Details |
| A46821 | 14687145 | Am J Gastroenterol | Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. | 2004 | Details |
| A46822 | 14653214 | Rinsho Byori | [Laboratory data for assessment of nutrition in liver disease--with special reference to alcoholic hepatitis and nonalcoholic steatohepatitis (NASH)]. | 2003 | Details |
| A46823 | 14633828 | Diabetes Care | Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. | 2003 | Details |
| A46824 | 14631466 | Can J Gastroenterol | The role of liver biopsy in the management of patients with liver disease. | 2003 | Details |
| A46825 | 14603113 | MedGenMed | Nonalcoholic fatty liver disease. | 2003 | Details |
| A46826 | 14593885 | Nihon Shokakibyo Gakkai Zasshi | [Nonalcoholic steatohepatitis due to Crohn disease: a lethal case report]. | 2003 | Details |
| A46827 | 14507639 | Am J Pathol | Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. | 2003 | Details |
| A46828 | 14506112 | JAMA | Diagnosis of nonalcoholic fatty liver disease. | 2003 | Details |
| A46829 | 14506111 | JAMA | Diagnosis of nonalcoholic fatty liver disease. | 2003 | Details |
| A46830 | 14499793 | Am J Gastroenterol | Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach. | 2003 | Details |
| A46831 | 14499766 | Am J Gastroenterol | Nonalcoholic fatty liver disease (NAFLD)--two decades later: are we smarter about its natural history? | 2003 | Details |
| A46832 | 12962450 | Indian J Gastroenterol | Nonalcoholic steatohepatitis, obesity and celiac disease. | 2003 | Details |
| A46833 | 12957298 | Alcohol | Iron as a co-morbid factor in nonhemochromatotic liver disease. | 2003 | Details |
| A46834 | 12920429 | Gastroenterol Nurs | Nonalcoholic Fatty liver disease. | 2003 | Details |
| A46835 | 12886827 | Ann Ital Med Int | [Multifactorial hepatopathy in a patient with biliopancreatic diversion]. | 2003 | Details |
| A46836 | 12884199 | Liver Transpl | Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: Implications for living liver donation. | 2003 | Details |
| A46837 | 12881873 | Zhejiang Da Xue Xue Bao Yi Xue Ban | [Liver fibrosis indexes in nonalcoholic fatty liver disease]. | 2003 | Details |
| A46838 | 12873608 | Am J Gastroenterol | Ultrastructure of hepatocyte mitochondria in nonalcoholic steatohepatitis in pediatric patients: usefulness of electron microscopy in the diagnosis of the disease. | 2003 | Details |
| A46839 | 12828075 | Hepatogastroenterology | Serum ubiquitin levels in patients with nonalcoholic steatohepatitis. | 2003 | Details |
| A46840 | 12809815 | Am J Gastroenterol | The prevalence and etiology of elevated aminotransferase levels in the United States. | 2003 | Details |
| A46841 | 12809814 | Am J Gastroenterol | Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence? | 2003 | Details |
| A46842 | 12792701 | Braz J Med Biol Res | A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid. | 2003 | Details |
| A46843 | 12779071 | Dig Liver Dis | Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. | 2003 | Details |
| A46844 | 12768390 | J Gastroenterol | Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver. | 2003 | Details |
| A46845 | 12713883 | J Hepatol | Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics. | 2003 | Details |
| A46846 | 12648420 | Zhonghua Gan Zang Bing Za Zhi | [Current therapy strategies for nonalcoholic fatty liver disease]. | 2003 | Details |
| A46847 | 12648414 | Zhonghua Gan Zang Bing Za Zhi | [Drug therapy for nonalcoholic fatty liver disease]. | 2003 | Details |
| A46848 | 12648413 | Zhonghua Gan Zang Bing Za Zhi | [The role of improving insulin-resistant in the treatment and prevention of nonalcoholic fatty liver disease]. | 2003 | Details |
| A46849 | 12648412 | Zhonghua Gan Zang Bing Za Zhi | [Treatment and prevention effects of weight loss on obese patients with nonalcoholic fatty liver disease]. | 2003 | Details |
| A46850 | 12648411 | Zhonghua Gan Zang Bing Za Zhi | [Therapeutic strategies for nonalcoholic fatty liver disease]. | 2003 | Details |
| A46851 | 12648394 | Zhonghua Gan Zang Bing Za Zhi | [Diagnostic criteria of nonalcoholic fatty liver disease]. | 2003 | Details |
| A46852 | 12642745 | J Clin Gastroenterol | Risk of cancer in patients hospitalized with fatty liver: a Danish cohort study. | 2003 | Details |
| A46853 | 12612935 | Gastroenterology | Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance. | 2003 | Details |
| A46854 | 12609055 | Zhonghua Gan Zang Bing Za Zhi | [Stress on research of nonalcoholic fatty liver disease]. | 2003 | Details |
| A46855 | 12591075 | Am J Gastroenterol | Current biochemical studies of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) suggest a new therapeutic approach. | 2003 | Details |
| A46856 | 12527713 | Mod Pathol | Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. | 2003 | Details |
| A46857 | 12512048 | Gastroenterology | Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. | 2003 | Details |
| A46858 | 12472968 | J Gastroenterol Hepatol | Treatment of non-alcoholic fatty liver disease. | 2002 | Details |
| A46859 | 12417056 | J Cell Mol Med | Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet. | 2003 | Details |
| A46860 | 12408779 | Curr Treat Options Gastroenterol | Therapeutic Options in Nonalcoholic Fatty Liver Disease. | 2002 | Details |
| A46861 | 12404245 | Gastroenterology | AGA technical review on nonalcoholic fatty liver disease. | 2002 | Details |
| A46862 | 12404244 | Gastroenterology | American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. | 2002 | Details |
| A46863 | 12235896 | Rev Med Chil | [Obesity: risk factor for steatohepatitis and hepatic fibrosis]. | 2002 | Details |
| A46864 | 12230315 | Semin Gastrointest Dis | Medical management of obesity. | 2002 | Details |
| A46865 | 12214633 | N Engl J Med | Nonalcoholic fatty liver disease. | 2002 | Details |
| A46866 | 12214632 | N Engl J Med | Nonalcoholic fatty liver disease. | 2002 | Details |
| A46867 | 12214631 | N Engl J Med | Nonalcoholic fatty liver disease. | 2002 | Details |
| A46868 | 12213955 | N Engl J Med | Nonalcoholic fatty liver disease. | 2002 | Details |
| A46869 | 12184161 | Arq Gastroenterol | [The importance of AST / ALT rate in nonalcoholic steatohepatitis diagnosis]. | 2002 | Details |
| A46870 | 12093239 | Ann Intern Med | Updated definitions of healthy ranges for serum alanine aminotransferase levels. | 2002 | Details |
| A46871 | 12053812 | Rev Invest Clin | [Analysis of liver biopsy experience in a regional hospital]. | 2002 | Details |
| A46872 | 12016429 | Gastroenterology | Nonalcoholic fatty liver disease. | 2002 | Details |
| A46873 | 12003426 | Am J Gastroenterol | Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. | 2002 | Details |
| A46874 | 12003400 | Am J Gastroenterol | Growth hormone plasma levels in nonalcoholic fatty liver disease. | 2002 | Details |
| A46875 | 11961152 | N Engl J Med | Nonalcoholic fatty liver disease. | 2002 | Details |
| A46876 | 11944632 | Semin Gastrointest Dis | Alcoholic steatosis and steatohepatitis. | 2002 | Details |
| A46877 | 19475216 | Rev Bras Anestesiol | Preanesthetic clinical problems of morbidly obese patients submitted to bariatric surgery: comparison with non-obese patiens. | 2002 | Details |
| A46878 | 11915019 | Hepatology | Nonalcoholic fatty liver disease: an agenda for clinical research. | 2002 | Details |
| A46879 | 11832442 | Gastroenterology | Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. | 2002 | Details |
| A46880 | 11825540 | Curr Gastroenterol Rep | Use of ursodeoxycholic acid in patients with liver disease. | 2002 | Details |
| A46881 | 11817771 | Indian J Gastroenterol | Nonalcoholic fatty liver disease in the Indian subcontinent: a medical consequence of globalization? | 2002 | Details |
| A46882 | 11755315 | Free Radic Biol Med | Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. | 2002 | Details |
| A46883 | 11589765 | Liver | Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases. | 2001 | Details |
| A46884 | 11447019 | Am J Physiol Gastrointest Liver Physiol | Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. | 2001 | Details |
| A46885 | 11391044 | Alcohol Clin Exp Res | Nonalcoholic fatty liver disease: implications for alcoholic liver disease pathogenesis. | 2001 | Details |
| A46886 | 11360453 | Dtsch Med Wochenschr | [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment]. | 2001 | Details |
| A46887 | 11319446 | Gastroenterol Clin Biol | [Non-alcoholic steatohepatitis with cirrhosis after raltitrexed administration]. | 2001 | Details |
| A46888 | 11303985 | Dig Liver Dis | Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. | 2001 | Details |
| A46889 | 11296700 | Semin Liver Dis | Animal models of steatosis. | 2001 | Details |
| A46890 | 11296699 | Semin Liver Dis | Treatment of nonalcoholic fatty liver: present and emerging therapies. | 2001 | Details |
| A46891 | 11296696 | Semin Liver Dis | Peroxisomal beta-oxidation and steatohepatitis. | 2001 | Details |
| A46892 | 11296693 | Semin Liver Dis | Clinical features and natural history of nonalcoholic steatosis syndromes. | 2001 | Details |
| A46893 | 11293184 | Indian J Gastroenterol | Nonalcoholic steatohepatitis. | 2001 | Details |
| A46894 | 11078773 | N Engl J Med | Cytokines in alcoholic and nonalcoholic steatohepatitis. | 2000 | Details |
| A46895 | 11059435 | Am J Med | Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. | 2000 | Details |
| A46896 | 11051414 | Am J Gastroenterol | Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history? | 2000 | Details |
| A46897 | 11032566 | Am J Med | Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity. | 2000 | Details |
| A46898 | 10980928 | Curr Gastroenterol Rep | Nonalcoholic fatty liver disease. | 2000 | Details |
| A46899 | 10811531 | Cell Biol Toxicol | Hepatotoxicity due to mitochondrial dysfunction. | 1999 | Details |
| A46900 | 10726383 | Gastroenterol Hepatol | [Steatosis and nonalcoholic steatohepatitis. A comparative analysis]. | 2000 | Details |
| A46902 | 35091576 | Nat Commun | Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease. | 2022 | Details |
| A46903 | 35053298 | Cells | NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease. | 2022 | Details |
| A46905 | 34970275 | Front Immunol | Macrophage Polarization and Its Role in Liver Disease. | 2021 | Details |
| A46906 | 34898362 | Bioengineered | microRNA-378b regulates ethanol-induced hepatic steatosis by targeting CaMKK2 to mediate lipid metabolism. | 2021 | Details |
| A46907 | 34896286 | Cell Mol Gastroenterol Hepatol | Bile Acid-Mediated Activation of Brown Fat Protects From Alcohol-Induced Steatosis and Liver Injury in Mice. | 2021 | Details |
| A46908 | 34817678 | Eur J Nutr | Betaine in ameliorating alcohol-induced hepatic steatosis. | 2021 | Details |
| A46909 | 34774847 | Am J Pathol | ZFP36L1 Regulates Fgf21 mRNA Turnover and Modulates Alcoholic Hepatic Steatosis and Inflammation in Mice. | 2021 | Details |
| A46910 | 34646717 | Alcohol Res | Hepatic Cannabinoid Signaling in the Regulation of Alcohol-Associated Liver Disease. | 2021 | Details |
| A46911 | 34558087 | Alcohol Clin Exp Res | A review of the role of ethanol-induced adipose tissue dysfunction in alcohol-associated liver disease. | 2021 | Details |
| A46912 | 34525389 | J Nutr Biochem | A mouse model of the regression of alcoholic hepatitis: Monitoring the regression of hepatic steatosis, inflammation, oxidative stress, and NAD+ metabolism upon alcohol withdrawal. | 2021 | Details |
| A46913 | 34523155 | Alcohol Clin Exp Res | A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice. | 2021 | Details |
| A46914 | 34513903 | Front Nutr | The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. | 2021 | Details |
| A46915 | 34428307 | Aliment Pharmacol Ther | Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation. | 2021 | Details |
| A46916 | 34423788 | JCI Insight | The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease. | 2021 | Details |
| A46918 | 34282217 | Sci Rep | Elevated S-adenosylhomocysteine induces adipocyte dysfunction to promote alcohol-associated liver steatosis. | 2021 | Details |
| A46919 | 34267188 | Cell Death Dis | Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. | 2021 | Details |
| A46920 | 34265279 | Biochem Pharmacol | PPARα agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic fat accumulation in mice lacking adipose FGFR1. | 2021 | Details |
| A46921 | 34229840 | Clin Liver Dis | Diagnosis of Alcohol-Associated Hepatitis: When Is Liver Biopsy Required? | 2021 | Details |
| A46922 | 34198609 | Cells | Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice. | 2021 | Details |